Indicated as monotherapy for Older people with HR-constructive, HER2-adverse Superior or metastatic breast cancer with disease development following endocrine therapy and prior chemotherapy in metastatic placing 200 mg PO BID Acceptable reports haven't been done on the connection of age to th